BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
IDBI Capital Report
Birlasoft Ltd. reported 3% constant currency growth in dollar revenues (excluding Invacare), better than peers. It is taking the right step to turnaround the business like focus on delivery, clients, investment in sales and hiring of leaders to drive vertical growth.
We expect the company to register QoQ growth in coming quarters led by banking, financial services and insurance, bottoming of enterprise resource planning business and healthy H2 FY24E.
However, we have conservatively assumed 6.5% YoY growth in revenues due to macro uncertainty, project run offs and Invacare base.
Birlasoft also aspires to reach 15-16% Ebitda margins in coming quarters. We have built in a 14.5% Ebitda margins for FY24E.
We have kept our estimates unchanged. However, we have revised our multiple upwards to 15 times (from 14 times) to factor in green shoots in turnaround.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
RECOMMENDED FOR YOU

M&M Q1 Review: Analysts See Rising Commodity Prices To Weigh


Varun Beverages Q2 Results Review — Yes Securities Maintains 'Buy', Revises Target Price


PM Modi's Deepfakes Used In New Financial Scam To Dupe Facebook Users


IndusInd Bank Q1 Results Review— Asset Quality Remains Under Pressure With No Signs Of Growth, Says Systematix
